Objective: To observe and valuate the efficacy of different treatments of acute non-ST-segment elevation myocardial infarction. Methods: 86 cases acute non-ST segment elevation myocardial infarction patients were retrospectively analyzed in emergency department of our hospital from January 2007 to March 2010. Then meta-analysis the efficacy of different treatment modalities and prognosis. Results: There had no significant difference between percutaneous transluminal coronary intervention (PCI) and general medical treatment of drug application (P＞0.05)., while clinical efficacy was superior to the general drug treatment. The incidence of cardiovascular events and mortality was also lower than the general drug treatment (P＜0.05). Conclusion: It is an effective means of common drug combined transluminal percutaneous coronary intervention in treating acute non-ST segment myocardial infarction. It can improve the prognosis significantly.%目的:观察急性非ST段抬高心肌梗死急诊患者不同诊疗方式的疗效,评价不同诊疗方式的临床应用价值.方法:回顾性分析我院急诊科于2007年1月～2010年3月收治抢救的急性非ST段抬高心肌梗死患者86例的临床资料,分析不同治疗方式的疗效及对预后的影响.结果:经皮冠状动脉腔内介入治疗(PCI)药物应用与普通药物治疗差异无统计学意义(P>0.05),临床疗效优于普通药物治疗,其心血管不良事件的发生率及死亡率也较普通药物治疗更低(P<0.05).结论:普通药物联合经皮冠状动脉腔内介入治疗是治疗急性非ST段心肌梗死的有效手段,可明显改善近期预后.
展开▼
